Skip to main content

What Is New In CAR T-Cell Therapy?

February 15, 2022

Join us for a free webinar covering the latest information for patients and caregivers.

To register by phone, call (866) 992-9950.

Program slides will be available the day of the program, on this page.

Topics Covered

We invite you to learn more about:

  • CAR T-cell (chimeric antigen receptor T-cell) therapy for blood cancer patients
  • Who may benefit from CAR T-cell therapy
  • Approved and emerging CAR T-cell therapies
  • The future of CAR T-cell therapy for blood cancer patients


David Miklos, MD, PhD
Chief, BMT and Cell Therapy Division
Professor of Medicine
Stanford University
Stanford, CA

Surbhi Sidana, MD
Assistant Professor of Medicine
Director, Myeloma Cellular Immunotherapy
Division of BMT & Cell Therapy,
Stanford University
Stanford, CA


Submit a question for Dr. Miklos or Dr. Sidana to answer during the Q&A session.


Program Support

Support for this program is provided by Bristol-Myers Squibb; CRISPR Therapeutics; Kite, a Gilead Company; and Novartis.


< Back to Webcasts